TPD52L2 and TPD52

  • Number of citations of the paper that reports this interaction (PMID 22863883)
  • 15
  • Data Source:
  • BioGRID (two hybrid, biochemical)
  • HPRD (two hybrid)

TPD52L2

TPD52

Gene Name tumor protein D52-like 2 tumor protein D52
Image No pdb structure No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Metabolite levels (HVA/MHPG ratio) ( 23319000)
Protein-Protein Interactions 7 interactors: ADORA2B APP MAL2 SH3GLB1 TPD52 TPD52L1 TPD52L3 8 interactors: ANXA6 MAL2 SENP2 SOCS2 SRPK2 TPD52L1 TPD52L2 TPD52L3
Entrez ID 7165 7163
HPRD ID 11947 04963
Ensembl ID ENSG00000101150 ENSG00000076554
Uniprot IDs O43399 Q68E05 Q6FGS1 P55327
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
anxa4  cacybp  cfl1  ciapin1  ctro  cytokinesis  fam50a  hspb1  incapable  mefs  migrated  nbs  ndrg  ndrg1  ndrg1expression  nsfl1c  pcbp2  pdap1  pml  proliferate  proliferated  relay  rsu1  stations  stmn1  sumo2  trio  ube2m  ywhag 
adjuvant  antigens  autoimmunity  broad  burden  class  considers  demonstrating  efforts  exhibiting  expected  focusing  highlighting  largest  obstacle  oncogenesis  overcome  overexpressed  perhaps  possibly  preclinical  preclude  presumed  promising  shed  subset  tolerance  understudied  vaccine 
Tagcloud (Difference) ?
anxa4  cacybp  cfl1  ciapin1  ctro  cytokinesis  fam50a  hspb1  incapable  mefs  migrated  nbs  ndrg  ndrg1  ndrg1expression  nsfl1c  pcbp2  pdap1  pml  proliferate  proliferated  relay  rsu1  stations  stmn1  sumo2  trio  ube2m  ywhag 
adjuvant  antigens  autoimmunity  broad  burden  class  considers  demonstrating  efforts  exhibiting  expected  focusing  highlighting  largest  obstacle  oncogenesis  overcome  overexpressed  perhaps  possibly  preclinical  preclude  presumed  promising  shed  subset  tolerance  understudied  vaccine 
Tagcloud (Intersection) ?